...
首页> 外文期刊>Nuclear Medicine Communications >Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
【24h】

Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.

机译:18F-FDG PET参数在晚期鼻咽癌患者中的临床应用:不同生存终点的预测作用以及对预后分层的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the prognostic impact of different 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography ((1)F-FDG PET) parameters in patients with advanced nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS: A total of 196 patients with primary stage III-IVb NPC were included in the study. The following parameters derived from pretreatment (1)F-FDG PET were determined: metabolic tumor volume and total lesion glycolysis (TLG) of the primary tumor, maximal standardized uptake value of the primary tumor and the neck lymph nodes. Multivariable Cox proportional hazards models were used to identify independent predictors of survival. RESULTS: Multivariable analysis demonstrated that TLG values greater than 330 independently predicted overall survival (P=0.0014) and disease-free survival (P=0.0005). We identified IVa-b stage and TLG values greater than 330 as independent predictors of local failure-free survival. In addition, a high maximal standardized uptake value of the neck lymph nodes (P=0.005), male sex (P=0.041), and stage IVa-b (P=0.009) independently predicted distant failure-free survival. A TLG cutoff value of 330 allowed a better stratification of overall survival and disease-free survival rates. A scoring system combining significant PET parameters and traditional prognostic factors was formulated to define distinct prognostic groups for local failure-free survival and distant failure-free survival. There was a stepwise decrease in the 5-year local (97.7, 90.4, and 47.3%, P<0.0001) and distant control rates (96.8, 88.5, 73.9, and 36.4%, P<0.0001) according to the distinct prognostic scores. CONCLUSION: In patients with advanced NPC, the prognostic significance of (1)F-FDG PET parameters seems to depend on the specific endpoint. The combination of PET metabolic parameters with traditional risk factors may significantly improve prognostic stratification for this group of patients.
机译:目的:研究不同的2- [氟-18]氟-2-脱氧-D-葡萄糖正电子发射断层扫描((1)F-FDG PET)参数对晚期鼻咽癌(NPC)患者的预后影响。患者与方法:总共196例原发性III-IVb期NPC患者被纳入研究。确定了来自预处理(1)F-FDG PET的以下参数:原发肿瘤的代谢肿瘤体积和总病变糖酵解(TLG),原发肿瘤和颈部淋巴结的最大标准化摄取值。多变量Cox比例风险模型用于确定生存的独立预测因子。结果:多变量分析表明,TLG值大于330可以独立预测总生存期(P = 0.0014)和无病生存期(P = 0.0005)。我们确定IVa-b分期和TLG值大于330是局部无衰竭生存的独立预测因子。此外,颈部淋巴结(P = 0.005),男性(P = 0.041)和IVa-b期(P = 0.009)的最高标准化摄取值独立地预测了远距离无衰竭生存期。 TLG临界值为330,可以更好地分层总体生存率和无病生存率。建立了将重要的PET参数和传统预后因素相结合的评分系统,以定义局部无故障生存期和远距无故障生存期的不同预后组。根据不同的预后评分,五年局部(97.7、90.4和47.3%,P <0.0001)和远距控制率(96.8、88.5、73.9和36.4%,P <0.0001)逐步降低。结论:在晚期NPC患者中,(1)F-FDG PET参数的预后意义似乎取决于特定终点。 PET代谢参数与传统危险因素的组合可以显着改善这一组患者的预后分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号